A New Immune-Biochemical Study To Identify Indicators Of The Response Of Infertile Polycystic Ovary Syndrome Patients To Metformin Treatment

    June 2025 in “ International Journal of Environmental Sciences ”
    Sura O. Yousif, Rasha Hasan Jasim
    Studysummary In this study, researchers found that serum levels of integrin, CLEC10A, and interleukin-42 significantly differed between PCOS patients treated with infertility drugs and untreated PCOS patients when compared to healthy controls, suggesting these biomarkers could help differentiate treatment status in PCOS.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on theaspd.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women JAMA Network Open · 2024
    2. Evaluating the Diagnostic Accuracy of Androgen Measurement in Polycystic Ovary Syndrome: A Systematic Review and Diagnostic Meta-Analysis to Inform Evidence-Based Guidelines Human Reproduction Update · 2024
    3. Targeting Integrin Pathways: Mechanisms and Advances in Therapy Signal Transduction and Targeted Therapy · 2023

    Related research 1

    1. Metformin: An Old Medication of New Fashion: Evolving New Molecular Mechanisms and Clinical Implications in Polycystic Ovary Syndrome European journal of endocrinology · 2009